Purpose
The purpose of these studies was to formulate mucoadhesive gels containing freeze dried black raspberries (FBR) and to determine optimum parameters for a subset of FBR bioactive compounds including anthocyanin stability, absorption and penetration in-vitro and in-vivo.
Materials and Methods
Berry gels were prepared having FBR at 5% and 10% w/w and final pHs ranging from 3.5 to 7.5. A HPLC assay was developed to quantify and determine the stability of the anthocyanins in the gels. A single time-point study was performed to determine anthocyanin uptake when the gels were applied to oral mucosa. Penetration of anthocyanins into human oral tissue explants was determined as a function of gel pH and FBR content. A HPLC-mass spectroscopy assay was utilized to quantify the anthocyanin levels in human oral tissue explants, saliva, and blood.
Results
The stability of anthocyanins in the gel was directly related to gel pH and storage temperature. Maximum stability of anthocyanins was found at lower pH (pH 3.5) and storage temperature (4°C). Anthocyanins contained in mucoadhesive berry gel formulations were readily absorbed into human oral mucosa tissue as evidenced by detectable blood levels within 5 min after gel application. There was a trend for greater penetration of anthocyanins into tissue explants for berry gels with a final pH of 6.5 versus pH 3.5.
Conclusions
Formulation and characterization of a novel gel formulation for local delivery of chemopreventive compounds to human oral mucosal tissues has been described. The results show anthocyanin stability was dependent upon gel pH and storage temperature and also demonstrate that the gel composition is well-suited for absorption and penetration into the target oral mucosal tissue site.
Similar content being viewed by others
References
A. Jemal, T. Murray, E. Ward, A. Samuels, R. C. Tiwari, A. Ghafoor, and E. J. Feuer. Thun MJ. Cancer statistics, 2005. CA: Cancer J. Clin. 55:10–11 (2005).
J. P. Malone, J. A. Stephens, J. C. Grecula, C. A. Rhoades, B. A. Ghaheri, and D. E. Schuller. Disease control, survival, and functional outcome after multimodal treatment for advanced-state tongue base cancer. Head Neck 26:561–572 (2004).
B. J. Braakhuis, M. P. Tabor, C. R. Leemans, I. van der Waal, G. B. Snow, and R. H. Brakenhoff. Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck 24:198–206 (2002).
K. A.Pathak, S. Gupta, S. Talole, V. Khanna, P. Chaturvedi, M. S. Deshpande, P. S. Pai, D. A. Chaukar, and A. K. D’Cruz. Advanced squamous cell carcinoma of lower gingivobuccal complex: patterns of spread and failure. Head Neck 27:597–602 (2005).
G. J. Schwartz, R. H. Mehta, B. L. Wenig, C. Shaligram, and L. G. Portugal. Salvage treatment for recurrent squamous cell carcinoma of the oral cavity. Head Neck 22:34–41 (2000).
A. Toma, L. Bonelli, A. Sartoris, E. Mira, A. Antonelli, F. Beatrice, C. Giordano, M. Benazzo, A. Caroggio, A. L. Cavalot, S. Gandolfo, A. Garozzo, G. Margarino, G. Schwnone, N. Spadini, Z. Sirotova, F. Zibordi, F. Balazarini, I. Serafini, P. Miani, and G. Cortesina. 13-cis retinoic acid in head and neck cancer chemoprevention: results of a randomized trial from the Italian head and neck chemoprevention study group. Oncol. Rep. 11:1297–1305 (2004).
V. A. Papadimitrakopoulou, G. L. Clayman, D. M. Shin, J. N. Myers, A. M. Gillenwater, H. Goepfert, A. K. El-Naggar, J. S. Lewin, S. M. Lippman, and W. K. Hong. Biochemoprevention for dysplastic lesions of the upper aerodigestive tract. Arch. Otolaryngol. Head Neck Surg. 125:1083–1089 (1999).
C. M. Rudin, E. E. W. Cohen, V. A. Pappdimitrakopoulou, S. Silverman, W. Recant, A. K. El-Naggar, K. Stenson, S. M. Lippman, W. K. Hong, and E. E. Vokes. An attenuated adnovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia. J. Clin. Oncol. 21:4546–4552 (2003).
A. Kresty, M. A. Morse, C. Morgan, P. S. Carlton, J. Lu, A. Gupta, M. Blackwood, and G. D. Stoner. Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized black raspberries. Cancer Res. 61:6112–6119 (2001).
B. C. Casto, L. A. Kresty, C. L. Kraly, D. K. Pearl, T. J. Knobloch, H. A. Schut, G. D. Stoner, S. R. Mallery, and C. M. Weghorst. Chemoprevention of oral cancer by black raspberries. Anticancer Res. 22:4005–4016 (2002).
H. Xue, R. M. Aziz, N. Sun, J. M. Cassady, L. M. Kamedulis, Y. Xu, G. D. Stoner, and J. E. Klaunig. Inhibition of cellular transformation by berry extracts. Carcinogenesis 22:351–356 (2001)
C. Huang, Y. Huang, J. Li, W. Hu, R. Aziz, M. S. Tang, N. Sun, J. Cassady, and G. D. Stoner. Inhibition of Benzo(a)pyrene diol-epoxide-induced transactivation of activated protein 1 and nuclear factor κB by black raspberry extracts. Cancer Res. 62:6857–6863 (2002).
K. A.Rodrigo, Y. Rawal, R. J. Renner, S. J. Schwartz, Q. Tian, P. E. Larsen, and S. R. Mallery. Suppression of the tumorigenic phenotype in squamous cell carcinoma cells by an ethanol extract derived from freeze-dried black raspberries. Nutr. Cancer 54:58–68 (2006).
G. D.Stoner, C. Sardo, G. Apseloff, D. Mullet, W. Wargo, V. Pound, A. Singh, J. Sanders, R. Aziz, B. Casto, and X. L. Sun. Pharmacokinetic of anthocyanins and ellagic acid in healthy volunteers fed freeze-dried black raspberries for 7 days. J. Clin. Pharmacol. 45:1153–1164 (2005).
S. S. Hecht, C. Huang, G. D. Stoner, J. Li, P. M. J. Kenney, S. J. Sturla, and S. G. Carmella. Identification of cyanidin glycosides as constituents of freeze-dried black raspberries which inhibit anti-benzo[a]pyrene-7,8-diol-9,10-epoxide induced NFκB and AP-1 activity. Carcinogenesis 27(8):1617–1626 (2006) August.
Q. Tian, M. M. Giusti, G. D. Stoner, and S. J. Schwartz. Characterization of a new anthocyanin in black raspberries (Rubus occidentalis) by liquid chromatography electrospray ionization tandem mass spectrometry. Food Chem. 94:465–468 (2005).
O.H.Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265–275 (1951).
M. Rubinskiene, I. Jasutiene, P. R. Venskutonis, and P. Viskelis. HPLC determination of the composition and stability of blackcurrant anthocyanins. J. Chromatogr. Sci. 43(9):478–482 (2005).
H. Morais, C. Ramos, E. Forgacs, T. Cserhati, and J. Oliviera. Influence of storage conditions on the stability of monomeric anthocyanins studied by reversed-phase high-performance liquid chromatography. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 25;770(1–2):297–301 (2002).
W.K. Hong, J. Endicott, L. M. Itri, W. Doos, J. G. Batsakis, R. Bell, S. Fofonoff, R. Byers, and E. N. Atkinson. 13-cis-retinoic acid in the treatment of oral leukoplakia. N. Eng. J. Med. 315:1501–1505 (1986).
S. M.Lippman, J. G. Batsakis, B. B. Toth, R. S. Weber, J. J. Lee, J. W. Martin, G. L. Hays, H. Goepfert, and W. K. Hong. Comparison of low-dose isoretinoin with beta-carotene to prevent oral carcinogenesis. N. Eng. J. Med. 328:15–20 (1993).
J. Han, L. Jiao, Y. Lu, Z. Sun, O. M. Gu, and K. J. Scalon. Evaluation of N-4-(hydroxycarbonphenyl) retinamide as a cancer prevention agent and as a cancer chemotherapeutic agent. In Vivo 4:153–160 (1990).
V. A. Papadimitrakopolou, W. K. Hong, J. S. Lee, J. W. Martin, J. J. Lee, J. G. Batsakis, and S. M. Lippman. Low-dose isoretinoin versus beta-carotene to prevent oral carcinogenesis: long term follow-up. J. Natl. Cancer Inst. 89:257–258 (1997).
F. Chiesa, N. Tradati, R. Grigolato, P. Boracchi, E. Biganzoli, N. Crose, E. Cavadini, F. Formelli, L. Costa, R. Giardini, S. Zurrida, A. Costa, G. De Palo, and U. Veronesi. Randomized trial of Fenretinide (4-HPR) to prevent recurrences, new localizations and carcinomas in patients operated on for oral leukoplakia: Long-term results. Int. J. Cancer 115:625–629 (2005).
M. Masuda, M. Suzui, and I. B. Weinstein. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin. Cancer Res. 7:4220–4229 (2001).
R. L. Eckert, J. F. Crish, T. Efimova, and S. Balasubramanian. Antioxidants regulate normal human keratinocyte differentiation. Biochem. Pharm. 68:1125–1131 (2004).
M. Liu, X. Q. Li, C. Weber, C. Y. Lee, J. Brown, and R. H. Liu. Antioxidant and antiproliferative activities of raspberries. J. Agric. Food Chem. 50:2926–2930 (2002).
D. B. Solt, K. W. Chang, I. Helenowski, and A. Rademaker. Phenethyl isothiocyanate inhibits nitrosamine carcinogenesis in a model for study of oral cancer chemoprevention. Cancer Lett. 202:147–152 (2003).
N. Katsube, K. Iwashita, T. Tsushida, K. Yamaki, and M. Kobori. Induction of apoptosis in cancer cells by Bilberry (Vaccinium myrtillus) and the anthocyanins. J. Agric. Food Chem. 51:68–75 (2003).
C. Hu, J. Zawistowski, W. Ling, and D. D. Kitts. Black rice (Oryza sativa L. Indica) pigmented fraction suppresses both reactive oxygen species and nitric oxide in chemical and biological model systems. J. Agric. Food Chem. 51:5271–5277 (2003).
C. D. Kay, G. J. Mazza, and B.J. Holub. Anthocyanins exist in the circulation primarily as metabolites in adult men. J. Nutr. 135(11):2582–2588 2005.
I. Bitsch, M. Janssen, M. Netzel, G. Strass, and T. Frank. Bioavailability of anthocyanidin-3-glycosides following consumption of elderberry extract and blackcurrant juice. Int. J. Clin. Pharmacol. Ther. 42(5):293–300 (2004).
H. Matsumoto, H. Inaba, M. Kishi, S. Tominaga, M. Hirayama, and T. Tsuda. Orally administered delphinidin 3-rutinoside and cyanidin 3-rutinoside are directly absorbed in rats and humans and appear in the blood as the intact forms. J. Agric. Food Chem. 49(3):1546–1551 (2001).
Acknowledgements
The authors would like to acknowledge funding from the NIH-NCI R21CA11120 to SRM, GDS, PEL, and RJM, as well as funding from the USDA GRT961914 to GDS, SRM, and PEL.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mallery, S.R., Stoner, G.D., Larsen, P.E. et al. Formulation and In-Vitro and In-Vivo Evaluation of a Mucoadhesive Gel Containing Freeze Dried Black Raspberries: Implications for Oral Cancer Chemoprevention. Pharm Res 24, 728–737 (2007). https://doi.org/10.1007/s11095-006-9192-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-006-9192-1